Activities in 2010, Priorities for 2011
|
|
|
- Rosamund Johnson
- 5 years ago
- Views:
Transcription
1 European Centre for Disease Prevention and Control Activities in 2010, Priorities for 2011 Presentation to ENVI Committee by Marc Sprenger, Director ECDC 27 October 2010
2 Part 1: Examples of ECDC s work
3 Total TB notification rates per 100,0000 population, Europe 2008 Source: ECDC / WHO Euro Joint surveillance report on tuberculosis in Europe, Stockholm, 2010.
4 TB notification rates in EU Higher incidence countries EU average Lower incidence countries Source: ECDC / WHO Euro Joint surveillance report on tuberculosis in Europe, Stockholm, 2010.
5 Proportion of notified TB cases with primary multidrug resistance, EU/EEA, 2008 < 1% 1 to 1.9% 2 to 5.9% > 6-10% > 10% Not included or not reporting * Multidrug-resistant tuberculosis (MDR TB) is defined as TB that is resistant at least to isoniazid (INH) and rifampicin (RMP), the two most powerful first-line anti-tb drugs.
6 Source: Getty Images LABORATORIES
7 HIV infections diagnosed in 2008 Total population Rate as number per million population Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, Stockholm, 2008
8 HIV infections, Transmission groups in EU/EEA countries Predominant transmission group: men who have sex with men Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, Stockholm, 2008
9 HIV infections diagnosed, 2008 Men who have sex with men Rate as number per million male population < Missing or excluded data Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, Stockholm, 2008
10 Mortality related to HBV and HCV Hepatocellular mortality ranges from; 0.68 per 100,000 men in Sweden and 8.03 in Bulgaria Note: Data for Belgium, Bulgaria, Estonia, Hungary, Latvia, Poland and Switzerland did not distinguish between HCC and other liver cancers Source: Boseti, 2008; La Vecchia, 2000
11 Antenatal screening programmes for Hepatitis B and C in EU/EEA, 2009 Source: ECDC Technical Report on Surveillance and Prevention of Hepatitis B and C in Europe, Stockholm, October 2010
12 West Nile fever: confirmed human cases, 1 July 28 September 2010 Source: ECDC Epidemiological Update on West Nile virus transmission in Europe, Stockholm, September
13 VECTOR Source: Centro Agricoltura Ambiente "G.Nicoli" - Sustenia S.r.l., Italy
14 Source:(c)2007 Jina Lee, Wikimedia Commons RESERVOIR
15 Source: Annick Lenglet, ECDC
16 Source: Annick Lenglet, ECDC
17 Source: ECDC
18 Signing of Seat Agreement, 30 June Source: ECDC
19 ECDC Staff, May 2010 Source: ECDC
20 Part 2 Priorities for 2011
21 ECDC priorities for 2011 continuation from previous years Core functions mandated by Founding Regulation EU wide surveillance of infectious diseases Scientific Advice Preparedness and Response Communication and Country Support Disease specific programmes covering some 50 key infectious diseases Antimicrobial resistance /healthcare associated infections Emerging and vector borne diseases Food and water borne diseases and zoonoses HIV/AIDS, Sexually Transmitted Infections, Hepatitis and other Blood Borne Viruses Respiratory diseases, especially TB and influenza Vaccine preventable diseases and invasive bacterial infections
22 2009 Source: ECDC 22
23 ECDC priorities for 2011 new priorities Focus on cross cutting issues Health / social determinants Climate change Public health laboratory capacity in Europe Modelling communicable diseases Increased emphasis on training activities Lessons learned from 2009 influenza A (H1N1) pandemic Substances of human origin Organisational efficiency Focus on organisational efficiency Reinforce activity based budgeting, performance indicators, quality control and evaluation of activities
24 Source: Getty Images LABORATORIES
25 SOCIAL DETERMINANTS Source: Wikimedia Commons
26 CLIMATE CHANGE Climate change impact on Tiger Mosquito distribution by 2030: minimal scenario (ECDC, 2009)
27 Climate change impact on Tiger Mosquito distribution by 2030: maximal scenario (ECDC, 2009)
28 Part 3 Consequences of our priorities for 2011
29 Consequences of new priorities Increased flexibility How ECDC uses its expert How ECDC uses budget ADVANTAGE Responsive to emerging needs and threats Maximises value for money More effective But a bit more complex to explain?
30 Always a priority - listening to Parliament!
Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area
Rapid communications Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area C Ködmön (csaba.kodmon@ecdc.europa.eu)
ECDC and Spanish Ministry of Health workshop:
ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,
Epidemiology of tuberculosis in Europe. Marieke J. van der Werf European Centre for Disease Prevention and Control Amsterdam, 22 September 2014
Epidemiology of tuberculosis in Europe Marieke J. van der Werf European Centre for Disease Prevention and Control Amsterdam, 22 September 2014 Tuberculosis surveillance in the EU Aim: To provide a complete
EU Actions in the Area of Communicable Disease Control. Ines Steffens Managing Editor Eurosurveillance
EU Actions in the Area of Communicable Disease Control Ines Steffens Managing Editor Eurosurveillance The Treaty Establishing the European Community Article 152 A high level of human health protection
Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary
Centers for Disease Control and Prevention (CDC) FY 2009 Budget Request Summary The President s FY 2009 Budget Request for the Centers for Disease Control and Prevention (CDC) discretionary funding is
Future infectious disease health threats faced by the EU and the implications for laboratory capacity
Future infectious disease health threats faced by the EU and the implications for laboratory capacity Mike Catchpole, Chief Scientist European Centre for Disease Prevention and Control Determinants of
ECDC s role in the fight against HIV/AIDS in Europe
European Centre for Disease Prevention and Control ECDC s role in the fight against HIV/AIDS in Europe Marita van de Laar, PhD Program Coordinator HIV/AIDS, STI, hepatitis HIV in Europe, Stockholm, 2 November
EVALUATION OF HEALTH THREATS: How the EU system functions Zsuzsanna Jakab, Director of ECDC, Informal Meeting of Health Ministers
EVALUATION OF HEALTH THREATS: How the EU system functions Zsuzsanna Jakab, Director of ECDC, Informal Meeting of Health Ministers Angers, 8 9 September 2008 ecdc.europa.eu Key message of presentation ECDC
Monthly measles and rubella monitoring report
SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data
Laboratory Services and Networks Your priorities?
12th Meeting Caribbean National Epidemiologists and Laboratory Directors September 17th-19th, 2014 POS, Trinidad and Tobago Laboratory Services and Networks Your priorities? Dr Cristina Gutierrez Laboratory
Tuberculosis Now! Jon S Friedland MA, FRCPE, FMedSci. Infectious Diseases & Immunity
Tuberculosis Now! Jon S Friedland MA, FRCPE, FMedSci Infectious Diseases & Immunity What is TB Now? Epidemiology including international migration Biomarkers New treatments TB notification rate per 1
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
SURVEILLANCE REPORT Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA March 2017 Summary This report describes the geographical and temporal distribution of multidrug-resistant
Shigellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods
Annual Epidemiological Report for 2016 Shigellosis Key facts Shigellosis is a relatively uncommon disease in the EU/EEA, but remains of concern in some countries and for some population groups. In 2016,
ECDC update to the EU Commission Think Tank on HIV/AIDS
ECDC update to the EU Commission Think Tank on HIV/AIDS Andrew Amato Head of HIV, STI and V. Hepatitis programme, ECDC Luxembourg, 10-11 December 2013 Outline Main ECDC reports published since last Think
Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Yersiniosis Key facts In 2015, 26 countries reported 7 279 confirmed yersiniosis cases in the EU/EEA. The overall notification rate was 2.0 cases
EU Health Programme: working together to improve public health in Europe
EU HEALTH PROGRAMME EU Health Programme: working together to improve public health in Europe A selection of Public Health Projects with an important impact for EU Member States EUROPEAN COMMISSION The
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA
Molecular typing for surveillance of multidrug-resistant tuberculosis in the EU/EEA January 2016 Summary This report describes the geographical and temporal distribution of multidrug-resistant (MDR) tuberculosis
HIV/AIDS Joint Action HA-REACT
HIV/AIDS Joint Action HA-REACT Matthias Schuppe Policy Officer Health Threats Unit DG Health and Food Safety European Commission Policy Framework on HIV/AIDS in EU and neighbouring countries Commission
HIV, HBV and HCV testing policy experiences and lessons learned.
HIV, HBV and HCV testing policy experiences and lessons learned. Contents HIV and viral hepatitis: distinct epidemics at different stages of evolution Epidemiology: transmission, prevalence, incidence
Preventing disease Promoting and protecting health
Preventing disease Promoting and protecting health CONTENTS Context Global Health Security what is it? Health security the perfect storm Regional Health Security what is it? Caribbean Regional Health Security:
Towards a coordinated risk assessment framework?
Towards a coordinated risk assessment framework? Zsuzsanna Jakab, ECDC Director 3 rd meeting of the Chairs of the Scientific Committees and Panels Stockholm, 6-7 November 2007 ecdc.europa.eu Content of
The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint
The current status of PrEP in Europe Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint DISCLOSURES I have received a research grant from Gilead Sciences awarded to my institution
Key issues for HIV testing and
Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe Key issues for HIV testing & counselling in Europe HIV epidemics
Measuring TB burden and access to TB services for people who inject drugs in the WHO European Region, 2010 and 2011
Measuring TB burden and access to TB services for people who inject drugs in the WHO European Region, 2010 and 2011 Annabel Baddeley Global TB Programme WHO, Geneva Outline of presentation Global and European
Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU
Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU N. Safrany European Commission Pr. A. Nicoll ECDC 2 nd WHO GAP mtg 12-14 July 2011 Background
Hepatitis A SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Hepatitis A Key facts In 2015, 29 EU/EEA countries reported a total of 12 641 cases of hepatitis A, 12 527 (99.1%) of which were confirmed. The
Preliminary Programme Be E.I.! 2013 Meeting of ECDC National Focal Points for Threat Detection
4 November 2013 ECDC, Stockholm, Sweden Preliminary Programme Be E.I.! 2013 Meeting of ECDC National Focal Points for Threat Detection Monday 4 November 09:00-09:30 Registration and coffee 09:30-10:00
Communicable diseases in the Mediterranean region
Meeting the needs of Mediterranean nations: transmissible diseases in the Mediterranean area This is a Platinum Open Access Journal distributed under the terms of the Creative Commons Attribution Non-Commercial
New trends in harm reduction in Europe: progress made challenges ahead
New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm
19-30 June 2004 UK PRESENTATION ON PREVENTION, INVESTIGATION AND CONTROL OF HUMAN INFECTIOUS DISEASE
19-30 June 2004 BWC MEETING OF EXPERTS JULY 2004: UK PRESENTATION ON PREVENTION, INVESTIGATION AND CONTROL OF HUMAN INFECTIOUS DISEASE Healthcare in the UK: recent organisational changes In the UK, a National
Viral Hepatitis Burden and Policy Directions in the European Region of WHO
Viral Hepatitis Burden and Policy Directions in the European Region of WHO Dr Nedret Emiroglu WHO Regional Office for Europe Brussels 14-15 October 2010 Global Burden of Chronic Viral Hepatitis 2.7% all
Drug-related infectious diseases
Drug-related infectious diseases Mike Catchpole Chief Scientist, European Centre for Disease Prevention and Control Tuesday 24th October 2017 Basic (Case) Reproduction Rate All you need to know to design
Tuberculosis surveillance in Germany. Data of the tuberculosis report 2013
1 Tuberculosis surveillance in Germany Data of the tuberculosis report 2013 Robert Koch Institute (RKI) Respiratory Infections Unit Outline 2 Tuberculosis notification system in Germany Epidemiological
The European Food- and Water-borne Diseases (FWD) Surveillance network Surveillance of STEC/VTEC infections in Europe
The European Food- and Water-borne Diseases (FWD) Surveillance network Surveillance of STEC/VTEC infections in Europe Johanna Takkinen, Coordinator of FWD programme, Surveillance Unit European Centre for
The National Board of Health and Welfare
The National Board of Health and Welfare Communicable disease prevention and control in Sweden National Board of Health and Welfare Swedish Institute for Infectious Disease Control County council County
Risk assessment group (RAG), between
Risk assessment group (RAG), between event identification and risk management. How is Belgium dealing with a crisis? Sophie Quoilin, MD SsID, 21 May 2015 Brussels Rue Juliette Wytsmanstraat 14 1050 Brussels
Establishment of networks of human and animal virology laboratories and medical entomology
Establishment of networks of human and animal virology laboratories and medical entomology Maria Grazia Dente, Flavia Riccardo and Silvia Declich CNESPS/Istituto Superiore di Sanità -ISS (Italy) Workshop
Lymphogranuloma venereum
Annual Epidemiological Report for 2015 Lymphogranuloma venereum Key facts In 2015, 1 787 cases of Lymphogranuloma venereum (LGV) were reported in 23 countries. Three countries (France, the Netherlands
Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia
Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia 11 October 2011 Moscow, Russian Federation Zsuzsanna Jakab WHO Regional Director for Europe Millennium
Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods
Annual Epidemiological Report for 2015 Trichinellosis Key facts In 2015, a total of 156 confirmed cases of trichinellosis was reported from 29 EU/EEA countries. The overall notification rate was 0.03 cases
DG SANTE actions under the CBRN Action Plan
DG SANTE actions under the CBRN Action Plan Antonis Lanaras DG SANTE C3 Crisis management and preparedness in health 10 th Meeting of the CoU on Secure, Safe and Resilient Societies CBRNE 8 March 2018,
UVRI ACHIEVEMENTS BY: EDWARD K. MBIDDE, DIRECTOR- UVRI
UVRI ACHIEVEMENTS BY: EDWARD K. MBIDDE, DIRECTOR- UVRI OUTLINE PRESENTATION Historical perspective Vision, Mission, Core values Functions of UVRI and achievements HISTORIC PERSPECTIVE Established in 1936
Promoting Public Health Dialogue between Asia and Europe
Promoting Public Health Dialogue between Asia and Europe ASEF Public Health Network Joint ECDC and ASEF workshop How can we be better prepared for the next global health threat? Planning and implementing
Public Health Challenges. Identified by Public Health England
Public Health Challenges Identified by Public Health England Environmental Public Health 1. Environmental Change and Health What environmental public health interventions can be identified and developed
Keeping Europe healthy: ECDC in action.
Keeping Europe healthy: ECDC in action www.ecdc.europa.eu Photo credits All photos ECDC, except: Front cover, middle; p 2; CDC. Courtesy of Cynthia Goldsmith; Jacqueline Katz; Sherif R. Zaki Page 4 stockxpert.com
10/07/18. Dr. Otilia Mårdh, ECDC. No conflicts of interest.
No conflicts of interest. Prevention and control of chlamydia in Europe from data to policies and testing recommendations Dr. Otilia Mårdh, ECDC 15th Congress of the European Society of Contraception and
Angelos Hatzakis. 10th Paris Hepatology Conference
Angelos Hatzakis Professor of Epidemiology and Preventive Medicine Faculty of Medicine National and Kapodistrian University of Athens Co-Chair, Hepatitis B and C Public Policy Association 10th Paris Hepatology
Research article.
Research article Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European
A bird s eye view on. The European Centre for Disease Prevention and Control ECDC
A bird s eye view on The European Centre for Disease Prevention and Control ECDC Control of infectious diseases : what European citizens expect Protection against disease pandemics (influenza) and antibiotic-resistant
Prevention and control of hepatitis B and C in the European Region of WHO
Prevention and control of hepatitis B and C in the European Region of WHO Viral Hepatitis Prevention Board Dr Nedret Emiroglu WHO Regional Office for Europe Burden of viral hepatitis in the European Region
CONCEPT NOTE. Addressing HIV and TB Challenges: from Donor Support to Sustainable Health Systems
CONCEPT NOTE Addressing HIV and TB Challenges: from Donor Support to Sustainable Health Systems Official event in the programme of the Estonian Presidency of the Council of the European Union Co-organised
HIV/AIDS DEPARTMENT GLOBAL HEPATITIS PROGRAMME
HIV/AIDS DEPARTMENT GLOBAL HEPATITIS PROGRAMME Technical considerations and case definitions for VIRAL HEPATITIS SURVEILLANCE Dr Yvan J-F Hutin Global Hepatitis Programme 01 FOUR MAIN HEPATITIS VIRUSES
Giardiasis (lambliasis)
SURVEILLANCE REPORT Annual Epidemiological Report for 2016 Giardiasis (lambliasis) Key facts In 2016, 18 985 confirmed giardiasis cases were reported in the EU/EEA, representing an increase of 5.3% from
Behavioural indicators in men who have sex with men
Behavioural indicators in men who have sex with men Dr. Brenda Spencer, IUMSP, Lausanne 13 th HIV/AIDS Think Tank Meeting First presented by Prof. Jonathan Elford, City University London European Parliament,
Globalization and Health The regional response
Zsuzsanna Jakab Director European Centre for Disease Prevention and Control (ECDC) IBA Annual Meeting Anthrax, SARS and Bioweaponry Is Globalisation Bad for Your Health? 28 September 2005, Prague Globalization
WHO: Forum Issue #02 Student Officer Position:
WHO: Topic B Forum : World Health Organization Issue #02 : Topic B: Preparing for a Global Health Crisis Student Officer : Samantha Portillo Position: Chair of the United Nations World Health Organization
Protecting European citizen s health ECDC, an added value for the OCTs?
European Centre for Disease Prevention and Control Protecting European citizen s health ECDC, an added value for the OCTs? Denis Coulombier, Head of the Unit for Preparedness and Response European Centre
Monitoraggio delle epatiti virali in Europa
Monitoraggio delle epatiti virali in Europa Pier Luigi Lopalco Università di Bari Roma, 17 Dicembre 2015 By courtesy of the Programme for HIV, STI and Viral Hepatitis B and C infections, ECDC Surveillance
Emerging epidemics: Will they derail progress? Eastern/Central Europe
Emerging epidemics: Will they derail progress? Eastern/Central Europe Marieta Simonova, MD Clinic of Gastroenterology, Military Medical Academy Sofia, Bulgaria Disclosures Speaker/Adviser for AbbVie, Gilead,
Achievements, challenges and major outputs 2016
European Centre for Disease Prevention and Control Achievements, challenges and major outputs 2016 Highlights from the Annual Report of the Director www.ecdc.europa.eu This digest offers a small selection
Health Security in Southeast Asia
Health Security in Southeast Asia J. Kevin Baird, Ph.D. P.T. Hygienica Jakarta Health Risks & Security What is health security? Awareness of possible threats Monitoring likely threats Minimizing likely
Review of 2011, Priorities for 2012
ECDC DIRECTOR S PRESENTATION Review of 2011, Priorities for 2012 ECDC Director s annual hearing with Committee on the Environment, Public Health and Food Safety (ENVI), European Parliament, Brussels 3
Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014
Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014 Dr. Nicole Werner-Keišs Lisbon, 16.10.2014 Outline Background, scope and objectives
VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology
VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology HIV stands for human immunodeficiency virus. If left untreated, HIV can lead to the disease AIDS (acquired immunodeficiency syndrome).
Epidemiology of different hepatides (B & C) in Lithuania
Epidemiology of different hepatides (B & C) in Lithuania IRMA Čaplinskienė SAULIUS Čaplinskas Head of HIV/AIDS/STI and Hepatitis Surveillance, Centre for Communicable Diseases and AIDS; National ECDC contact
XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps
XDR-TB Extensively Drug-Resistant Tuberculosis What, Where, How and Action Steps The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever
AOHS Global Health. Unit 1, Lesson 3. Communicable Disease
AOHS Global Health Unit 1, Lesson 3 Communicable Disease Copyright 2012 2016 NAF. All rights reserved. A communicable disease is passed from one infected person to another The range of communicable diseases
TB/HIV in the WHO European Region Overview, Priorities & Response
TB/HIV in the WHO European Region Overview, Priorities & Response 16 th Core Group Meeting TB/HIV Working Group Stop TB Partnership Almaty, Kazakhstan May 2010 Martin Donoghoe Andrei Dadu, Smiljka de Lussigny
IHI Biomedical Sciences Group. Joseph Mugasa, PhD, PD. Stakeholders Meeting
IHI Biomedical Sciences Group Joseph Mugasa, PhD, PD Stakeholders Meeting Jan 2013 Overview Biomedical group carries out a range of laboratory studies with the aim of understanding the pathogenesis, diagnosis
Need for Chronic Viral Hepatitis Monitoring System
Need for Chronic Viral Hepatitis Monitoring System Harry L.A. Janssen Dept. of Gastroenterology & Hepatology Erasmus University Medical Center Rotterdam The Netherlands Rotterdam November 2008 National
COMMISSION OF THE EUROPEAN COMMUNITIES REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT
EN EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 15.5.2009 COM(2009) 228 final REPORT FROM THE COMMISSION TO THE COUNCIL AND THE EUROPEAN PARLIAMENT Operation of the Early Warning and Response
On behalf of the Infectious Diseases Society of America (IDSA), I offer testimony in
Testimony of the Infectious Diseases Society of America (IDSA) on the Fiscal Year 2018 Department of Health and Human Services Budget Prepared for the U.S. House of Representatives Subcommittee on Labor-HHS-Education
Official Journal of the European Union
L 39/6 16.2.2017 COMMISSION IMPLEMTING DECISION (EU) 2017/263 of 14 February 2017 on risk mitigating and reinforced biosecurity measures and early detection systems in relation to the risks posed by wild
CONTACTS & ACKNOWLEDGEMENTS
CONTACTS & ACKNOWLEDGEMENTS Snohomish Health District Communicable Disease Surveillance and Response Analysis and publication: Hollianne Bruce, MPH Program Manager: Amy Blanchard, RN, BSN Communicable
SURVEILLANCE REPORT. Annual epidemiological report. Respiratory tract infections tuberculosis.
SURVEILLANCE REPORT Annual epidemiological report Respiratory tract infections tuberculosis 2014 www.ecdc.europa.eu ECDC SURVEILLANCE REPORT Annual epidemiological report Respiratory tract infections -
SURVEILLANCE REPORT. Annual epidemiological report. Sexually transmitted infections, including HIV and blood-borne viruses.
SURVEILLANCE REPORT Annual epidemiological report Sexually transmitted infections, including HIV and blood-borne viruses 2014 www.ecdc.europa.eu ECDC SURVEILLANCE REPORT Annual epidemiological report Sexually
WINTER SEASON 2016/17 MORTALITY SUMMARY REPORT FROM THE EUROMOMO NETWORK
WINTER SEASON 2016/17 MORTALITY SUMMARY REPORT FROM THE EUROMOMO NETWORK Pooled analysis of all-cause and influenza-attributable mortality from 21 European countries participating in the EuroMOMO network
Vaccine preventable diseases
Vaccine preventable diseases National Immunisation Study Day Jan.17, 2012 Dr Kevin Connolly Infectious Disease Mortality, United States 20 th Century Armstrong, et al. JAMA 1999;281:61-66. Cases of Vaccine
Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)
Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous) 25 th Conference of the OIE Regional Commission for Europe 17 th to 21 st September 2012, Fleesensee Germany
Influenza A(H1N1)2009 pandemic Chronology of the events in Belgium
Arch Public Health 2010, 68, 48-52 Influenza A(H1N1)2009 pandemic Chronology of the events in Belgium by Litzroth A 1, Gutiérrez I 1,2, Hammadi S 1 Keywords Belgium, chronology, epidemiology, influenza
EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL?
8 th International Conference GLOBAL HEALTH CONSORTIUM Building Alliances in Global Health Miami, May 22-25, 2018 EPIDEMICS AND PANDEMICS: PREDICTION, PREVENTION, CONTROL? José Esparza MD, PhD - Adjunct
Communicable Diseases
Chapter 23 Communicable Diseases Disease that s spread from one living organism to another or through the environment Infection occurs when pathogens in the body multiply and damage body cells Main Pathogens
Infectious Disease Surveillance in NZ. Michael Baker Department of Public Health, University of Otago, Wellington
Infectious Disease Surveillance in NZ Michael Baker Department of Public Health, University of Otago, Wellington michael.baker@otago.ac.nz Outline Current best practice High quality surveillance of specific
FY2019 Labor, Health and Human Services, Education Appropriations Summary
Labor, Health and Human Services, Education Appropriations Summary NACCHO Priority Public Health Program Funding The Senate Appropriations Committee marked-up a bill funding the Departments of Labor, Health
Infection Control in the School Setting. It s In Your Hands
Infection Control in the School Setting It s In Your Hands What is an Infection? A condition resulting from the presence of, and invasion by, germs (microorganisms) For Infection to Occur an Organism Must:
Table Of Content. SSI_FY Summary... 3 Coordinator, Leader contact and partners... 7 Outputs... 8
Table Of Content SSI_FY2014... 2 Summary... 3 Coordinator, Leader contact and partners... 7 Outputs... 8 D01 - EuroMOMO system (EN)... 8 D02 - EuroMOMO website (EN)... 8 D03 - End of influenza season mortality
The surveillance and control of communicable diseases is a key role of
Communicable Disease Report 2002 Message from the Medical Officer of Health The surveillance and control of communicable diseases is a key role of public health. In the 19th- and early 20th-century, diseases
ECDC Annual Work Programme 2008
ECDC Annual Work Programme 2008 Document Approved by the ECDC Management Board at its 11 th meeting in Stockholm, 13-14 December 2007, including suggestions made at that meeting Table of Contents Executive
AREAS OF CONCENTRATION
Dr. Shruti Mehta, Director The development of antibiotics, improved access to safe food, clean water, sewage disposal and vaccines has led to dramatic progress in controlling infectious diseases. Despite
Multi-sectoral aspects of pandemic preparedness and response
Multi-sectoral aspects of pandemic preparedness and response Best practices, challenges and lessons learned in the EU International Ministerial Conference on Avian & Pandemic Influenza Sharm el Sheikh,
Highly pathogenic avian influenza "The Epidemic" Regionalisation in the European Union
Highly pathogenic avian influenza "The 2016-2017 Epidemic" Regionalisation in the European Union Andrea Gavinelli, Head of Unit G3 Official controls and eradication of diseases in animals European Commission
Hepatitis C in the WHO European Region
Hepatitis C in the WHO European Region Antons Mozalevskis WHO Regional Office for Europe Drug-related infectious disease (DRID) annual expert meeting 15 16 June 2015, EMCDDA Lisbon Burden of viral hepatitis
NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen
NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, 2011 Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen NDPHS Goals for the HIV/AIDS & AI Expert Group Goal 2: Prevention
WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network
WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network Tokyo, July 2009 World Bank Response to A(H1N1) Influenza A(H1N1) Global Health and Risks
EMPOWERING CIVIL SOCIETY AND PUBLIC HEALTH SYSTEM TO FIGHT TUBERCULOSIS EPIDEMIC AMONG VULNERABLE GROUPS
EMPOWERING CIVIL SOCIETY AND PUBLIC HEALTH SYSTEM TO FIGHT TUBERCULOSIS EPIDEMIC AMONG VULNERABLE GROUPS Cinthia Menel Lemos cinthia.menel-lemos@ec.europa.eu Project Officer Executive Agency for Health
HEV Update Blood Components. Dragoslav Domanović, European Centre for Disease Prevention and Control (Sweden)
HEV Update Blood Components Dragoslav Domanović, European Centre for Disease Prevention and Control (Sweden) Outline ECDC activities started in 2015 to understand the epidemiology and burden of HEV infection
Table Of Content. The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...
Table Of Content The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Institut Pasteur... 6 Health Division... 6 Nphs Communicable Disease Surveillance
Measles and rubella monitoring January 2015
Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period
Detailed description of Continuous Professional Development (CPD) activities
Catalogue 2018 ECDC Continuous Professional Development (CPD) on cross-border communicable disease prevention and control PART II - Detailed description of activities Detailed description of Continuous
HIV AIDS and Other Infectious Diseases
HIV AIDS and Other Infectious Diseases Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Chapter 1 - Introduction Despite the availability of a vaccine since